Indian prazosin market is estimated to decline during the forecast period. Despite that, a significant prevalence of high blood pressure in the country is further expected to contribute to the market share in the country. For instance, a team of scientists from India found that one in five young adults in India, which amounts to 80 million people, has the problem of high blood pressure. The researchers presented these results at the 70th Annual Conference of the Cardiological Society of India in 2018. High blood pressure is the leading cause of premature death. In addition, individuals with high blood pressure are at risk of contracting a host of other health conditions, such as heart attack, stroke, heart failure, atrial fibrillation, chronic kidney disease, and cognitive decline. In India, Sanosin (Prazosin) is used for the treatment of all grades of essential (primary) hypertension and all grades of secondary hypertension.
Get Free Sample link @ https://www.omrglobal.com/request-sample/indian-prazosin-market
Indian prazosin market is segmented on the basis of application. Based on the application, the market is segmented into cardiovascular disease, neurological syndromes, prostate disorders, and kidney disorders. The CVD segment accounted for the significant share in the Indian prazosin market. CVDs claim to take more lives each year than all forms of cancer and chronic lower respiratory diseases altogether. Thus, Prazosin is one of the treatments used for CVD mainly high BP and strokes. For instance, Minipress is specified for the treatment of hypertension, to control BP. Lowering blood pressure decreases the risk of fatal and nonfatal cardiovascular events, mainly strokes and myocardial infarction.
A full report of Indian Prazosin Market available @ https://www.omrglobal.com/industry-reports/indian-prazosin-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Indian Prazosin Market by Application
- Cardiovascular Disease( CVD)
- Neurological Syndromes
- Prostate Disorders
- Kidney Disorders
Company Profiles
- Ajinomoto Co., Inc.
- Johnlee Pharmaceuticals Pvt. Ltd.
- Merck KGaA
- Pfizer Inc.
- R&D Systems Inc.
- Renata Ltd.
- Mylan N.V.
- Standard Chem and Pharmaceuticals Co. Ltd.
- Sun Pharmaceuticals Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
The Report Covers
- Comprehensive research methodology of the Indian prazosin market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Indian prazosin market.
- Insights about market determinants which are stimulating the Indian prazosin market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indian-prazosin-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
